Drug
MRX-7EAT
MRX-7EAT is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
3(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 33 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_3
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains
NCT01198834
completedphase_3
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder
NCT01161615
completedphase_3
Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder
NCT01506154
Clinical Trials (3)
Showing 3 of 3 trials
NCT01198834Phase 3
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains
NCT01161615Phase 3
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder
NCT01506154Phase 3
Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3